The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
Open accessAbstract
Background & Aims The relations of non-alcoholic fatty liver disease to cardiovascular disease (CVD) risk factors are not fully understood. The objective of our study is to explore the bi-directional relationships of fatty liver to CVD risk factors. Methods We prospectively evaluated whether liver fat predicted the development of CVD risk factors and whether CVD risk factors predicted new onset fatty liver during 6 years of follow up in middle- to older-aged Framingham Heart Study participants. We estimated liver fat using multi-detector computed tomography. Results We included 1,051 participants (mean age 45 ± 6 years, 46% women). The prevalence of fatty liver was 18% at baseline. In participants without fatty liver at baseline, 101 participants developed incident fatty liver over approximately 6 years. Baseline liver fat (per standard deviation increase) was associated with increased odds of incident hypertension (OR 1.42; 95% CI 1.15-1.76; p=0.001) and incident type 2 diabetes (OR 1.43; 95% CI 1.09-1.88, p<0.001). In a parallel analysis, individuals with hypertension (OR 3.34; 95% CI 2.04-5.49), hypertriglyceridemia (OR 3.04; 95% CI:1.84-5.02), impaired fasting glucose (OR 2.92; 95% CI 1.76-4.82), or type 2 diabetes (OR 4.15; 95% CI 1.19-14.46) at baseline had higher odds of incident fatty liver compared to individuals without those conditions (all p<0.03). In both analyses, the observed associations remained similar after additional adjustments for measures of adiposity. Conclusions The present study demonstrated bi-directional relationships between fatty liver and CVD risk factors among middle- to older-aged Framingham Heart Study participants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Self-citationHuman Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Body Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481
Research works printed but not linked: 38
- Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762 · DOI · Paper page
- Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharmacol Ther, 34, 274, 10.1111/j.1365-2036.2011.04724.x · DOI · Paper page
- McCullough, 2004, The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease, Clin Liver Dis, 8, 521, 10.1016/j.cld.2004.04.004 · DOI · Paper page
- Feitosa, 2013, Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease, Atherosclerosis, 227, 420, 10.1016/j.atherosclerosis.2013.01.013 · DOI
- Hamaguchi, 2007, Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease, World J Gastroenterol, 13, 1579, 10.3748/wjg.v13.i10.1579 · DOI · Paper page
- Targher, 2016, Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis, J Hepatol, 65, 589, 10.1016/j.jhep.2016.05.013 · DOI · Paper page
- Speliotes, 2010, Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study, Hepatology, 51, 1979, 10.1002/hep.23593 · DOI · Paper page
- Splansky, 2007, The Third Generation Cohort of the National Heart, Lung, and Blood Institute’s Framingham Heart Study: design, recruitment, and initial examination, Am J Epidemiol, 165, 1328, 10.1093/aje/kwm021 · DOI · Paper page
- Speliotes, 2008, Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study, J Gastroenterol Hepatol, 23, 894, 10.1111/j.1440-1746.2008.05420.x · DOI
- Porter, 2013, Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study, Arterioscler Thromb Vasc Biol, 33, 139, 10.1161/ATVBAHA.112.300075 · DOI
- Roseman, 2014, Renal artery calcium, cardiovascular risk factors, and indexes of renal function, Am J Cardiol, 113, 156, 10.1016/j.amjcard.2013.09.036 · DOI
- Rosenquist, 2013, Visceral and subcutaneous fat quality and cardiometabolic risk, JACC Cardiovasc Imaging, 6, 762, 10.1016/j.jcmg.2012.11.021 · DOI · Paper page
- Mellinger, 2015, Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study, J Hepatol, 63, 470, 10.1016/j.jhep.2015.02.045 · DOI · Paper page
- Preis, 2009, Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study, Circulation, 120, 212, 10.1161/CIRCULATIONAHA.108.846519 · DOI · Paper page
- Walsh, 2002, Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study, Ann Intern Med, 136, 181, 10.7326/0003-4819-136-3-200202050-00005 · DOI · Paper page
- Kotronen, 2008, Fatty liver: a novel component of the metabolic syndrome, Arterioscler Thromb Vasc Biol, 28, 27, 10.1161/ATVBAHA.107.147538 · DOI · Paper page
- Hsiao, 2007, Significant correlations between severe fatty liver and risk factors for metabolic syndrome, J Gastroenterol Hepatol, 22, 2118, 10.1111/j.1440-1746.2006.04698.x · DOI
- Kotronen, 2007, Liver fat in the metabolic syndrome, J Clin Endocrinol Metab, 92, 3490, 10.1210/jc.2007-0482 · DOI · Paper page
- Gustafson, 2007, Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis, Arterioscler Thromb Vasc Biol, 27, 2276, 10.1161/ATVBAHA.107.147835 · DOI · Paper page
- Musso, 2011, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Ann Med, 43, 617, 10.3109/07853890.2010.518623 · DOI · Paper page
- Fraser, 2009, Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis, Diabetes Care, 32, 741, 10.2337/dc08-1870 · DOI · Paper page
- Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41 · DOI · Paper page
- Neeland, 2012, Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults, JAMA, 308, 1150, 10.1001/2012.jama.11132 · DOI · Paper page
- Ryoo, 2014, Clinical association between non-alcoholic fatty liver disease and the development of hypertension, J Gastroenterol Hepatol, 29, 1926, 10.1111/jgh.12643 · DOI
- Sung, 2014, Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension, J Hepatol, 60, 1040, 10.1016/j.jhep.2014.01.009 · DOI
- Zhang, 2015, Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study, Atherosclerosis, 240, 144, 10.1016/j.atherosclerosis.2015.02.049 · DOI
- Tsuneto, 2010, Fatty liver incidence and predictive variables, Hypertens Res, 33, 638, 10.1038/hr.2010.45 · DOI
- Lonardo, 2015, Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome, Dig Liver Dis, 47, 181, 10.1016/j.dld.2014.09.020 · DOI · Paper page
- Wong, 2015, Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy, J Hepatol, 62, 182, 10.1016/j.jhep.2014.08.041 · DOI · Paper page
- Zhang, 2014, Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study, PLoS One, 9
- Fan, 2007, Effects of nonalcoholic fatty liver disease on the development of metabolic disorders, J Gastroenterol Hepatol, 22, 1086, 10.1111/j.1440-1746.2006.04781.x · DOI · Paper page
- Lawlor, 2008, Mendelian randomization: using genes as instruments for making causal inferences in epidemiology, Stat Med, 27, 1133, 10.1002/sim.3034 · DOI · Paper page
- Roberts, 2013, Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training, Compr Physiol, 3, 1, 10.1002/j.2040-4603.2013.tb00484.x · doi:10.1002/j.2040-4603.2013.tb00484.x · Paper page
- Itani, 2002, Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha, Diabetes, 51, 2005, 10.2337/diabetes.51.7.2005 · DOI · Paper page
- Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 · DOI · Paper page
- Zezos, 2014, Liver transplantation and non-alcoholic fatty liver disease, World J Gastroenterol, 20, 15532, 10.3748/wjg.v20.i42.15532 · DOI
- Kemmer, 2013, Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation, Transplantation, 96, 860, 10.1097/01.TP.0000436723.59879.01 · DOI
- Saadeh, 2002, The utility of radiological imaging in nonalcoholic fatty liver disease, Gastroenterology, 123, 745, 10.1053/gast.2002.35354 · DOI · Paper page
Cited by
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Mantovani, A., Byrne, C. D., Bonora, E., & Targher, G. (2018) · Diabetes Care · doi:10.2337/dc17-1902 · Cited by 624
Wong, V. W., Chan, W., Chitturi, S., Chawla, Y., Dan, Y. Y., Duseja, A., Fan, J., Goh, K., Hamaguchi, M., Hashimoto, E., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13857 · Cited by 506
Nonalcoholic Fatty Liver Disease and the Heart
Stahl, E. P., Dhindsa, D. S., Lee, S. K., Sandesara, P. B., Chalasani, N. P., & Sperling, L. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.050 · Cited by 439
Metadata
- Authors
- Ma, J., Hwang, S.-J., Pedley, A., Massaro, J. M., Hoffmann, U., Chung, R. T., Benjamin, E. J., Levy, D., Fox, C. S., & Long, M. T.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 66
- Issue
- 2
- Pages
- 390-397
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2550685331
- Cited by
- 234
- References
- 4
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bi-directional analysis between fatty liver and cardiovascular disease risk factors. https://app.cochat.ai/papers/10.1016/j.jhep.2016.09.022
- The paper
- Ma, J., Hwang, S.-J., Pedley, A., Massaro, J. M., Hoffmann, U., Chung, R. T., Benjamin, E. J., Levy, D., Fox, C. S., & Long, M. T. (2017). Bi-directional analysis between fatty liver and cardiovascular disease risk factors. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2016.09.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.